ArticleEvidence-based complementary and alternative medicine : eCAM2004
Comparative Electropharmacological Actions of Some Constituents from Ginkgo biloba Extract in Guinea-pig Ventricular Cardiomyocytes.
Article in Evidence-based complementary and alternative medicine : eCAM, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- Ginkgo Biloba: Plant-Based Proarrhythmic Potential?JACC. Case reports · 2020Article
- Effect of Yin-Xing-Tong-Zhi Tablets on Improving Vascular Cognitive Impairment No Dementia.Evidence-based complementary and alternative medicine : eCAM · 2018Article
- Possible Involvement of Ca Activated K Channels, SK Channel, in the Quercetin-Induced Vasodilatation.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2009Article
- CAM and cell fate targeting: molecular and energetic insights into cell growth and differentiation.Evidence-based complementary and alternative medicine : eCAM · 2005Article
- Pharmacological effectiveness of the active phytochemicals contained in foods and herbs.Journal of intercultural ethnopharmacologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effects of the constituents from Ginkgo biloba extract (GBE) on the action potentials and the ionic currents in guinea pig ventricular cardiomyocytes were investigated using whole-cell and current-clamp techniques. The constituents, ginkgolides A, B, C and quercetin, had depressant effects at 0.1-3muM on the action potential configuration. Ginkgolide A (1-3 muM) prolonged the action potential (action potential duration: APD) at 75% and 90% repolarizations (APD(75) and APD(90)). However, ginkgolides B and C at low concentrations prolonged APD, but at higher concentrations (>1 muM) shortened APD. Quercetin at 3 muM prolonged the APD, but not at the lower concentrations. These constituents also inhibited the V(max). The resting potential was unaffected. In voltage-clamp experiments, ginkgolides A and B (0.1-3 muM) markedly and concentration-dependently increased the Ca(2+) current (I(Ca)) and the delayed rectifier K(+) current (I(K)), and decreased the inwardly rectifying K(+) current (I(K1)). On the other hand, ginkgolide C failed to affect the I(Ca) but increased the I(K) by 14.0 +/- 2.3% (n = 6, P < 0.05) at 1 muM. Quercetin inhibited I(Ca), and enhanced I(K) but decreased I(K1). These responses to the constituents were almost reversible (80-90% of control) after a 10- to 20-min washout. These results indicate that even at acute administrations, these constituents produce the effective actions on the APD and the underlying ionic currents in cardiomyocytes. Each constituent does not exhibit a uniform response, although GBE acts as a net.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.